NYSE:SYK - Stryker Stock Price, Forecast & News

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SYK stock has decreased by 17.6% and is now trading at $144.67. View which stocks have been mosted impacted by Coronavirus.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 1 sell rating, 6 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker.

Stryker is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for Stryker.

Stryker Co. (NYSE:SYK) released its quarterly earnings results on Tuesday, January, 28th. The medical technology company reported $2.49 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.46 by $0.03. The medical technology company had revenue of $4.13 billion for the quarter, compared to the consensus estimate of $4.11 billion. Stryker had a net margin of 13.99% and a return on equity of 25.75%. The company's revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter last year, the business earned $2.18 earnings per share. View Stryker's earnings history.

Stryker announced a quarterly dividend on Friday, February 7th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.575 per share on Thursday, April 30th. This represents a $2.30 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date of this dividend is Monday, March 30th. View Stryker's dividend history.

Stryker updated its FY20 earnings guidance on Tuesday, January, 28th. The company provided earnings per share guidance of $9.00-9.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.04.

22 brokerages have issued 12-month price objectives for Stryker's shares. Their forecasts range from $145.00 to $248.00. On average, they anticipate Stryker's stock price to reach $211.10 in the next twelve months. This suggests a possible upside of 45.9% from the stock's current price. View analysts' price targets for Stryker.

News headlines about SYK stock have trended very negative this week, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Stryker earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave media coverage about the medical technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutStryker.

Stryker saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 5,538,700 shares, an increase of 43.9% from the February 27th total of 3,850,000 shares. Based on an average daily volume of 1,640,000 shares, the days-to-cover ratio is currently 3.4 days. Approximately 1.6% of the company's stock are sold short. View Stryker's Current Options Chain.

Some companies that are related to Stryker include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Insulet (PODD), Masimo (MASI) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Medtronic (MDT), Visa (V), AbbVie (ABBV), Home Depot (HD), Boeing (BA), NVIDIA (NVDA), Bank of America (BAC) and QUALCOMM (QCOM).

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker's stock is owned by many different institutional and retail investors. Top institutional investors include Bath Savings Trust Co (0.02%) and First Financial Bank Trust Division (0.01%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker. View institutional ownership trends for Stryker.

SYK stock was bought by a variety of institutional investors in the last quarter, including Bath Savings Trust Co, and First Financial Bank Trust Division. View insider buying and selling activity for Stryker.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $144.67.

Stryker has a market capitalization of $54.23 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe. View additional information about Stryker.

The official website for Stryker is http://www.strykercorp.com/.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]